Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women

This study has been completed.
Information provided by:
Baskent University Identifier:
First received: February 26, 2007
Last updated: NA
Last verified: February 2007
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: March 2006
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):